Abstract
Purpose
To evaluate the role of diffusion kurtosis and diffusivity as potential imaging biomarkers to predict response to neoadjuvant chemoradiation therapy (CRT) from baseline staging magnetic resonance imaging (MRI) in locally advanced rectal cancer (LARC).
Materials and methods
This retrospective study included 45 consecutive patients (31 male/14 female) who underwent baseline MRI with high b-value sequences (up to 1500 mm/s2) for LARC followed by neoadjuvant chemoradiation and surgical resection. The mean age was 57.4 years (range 34.2–72.9). An abdominal radiologist using open source software manually segmented T2-weighted images. Segmentations were used to derive diffusion kurtosis and diffusivity from diffusion-weighted images as well as volumetric data. These data were analyzed with regard to tumor regression grade (TRG) using the four-tier American Joint Committee on Cancer (AJCC) classification, TRG 0–3. Proportional odds regression was used to analyze the four-level ordinal outcome. A sensitivity analysis was performed using univariable logistic regression for binary TRG groups, TRG 0/1 (> 90% response), or TRG 2/3 (< 90% response). p < 0.05 was considered significant throughout.
Results
In the univariable proportional odds regression analysis, higher diffusivity summary (Dsum) values were observed to be significantly associated with higher odds of being in one or more favorable TRG group (TRG 0 or 1). In other words, on average, patients with higher Dsum values were more likely to be in a more favorable TRG group. These results are mostly consistent with the sensitivity analysis, in which higher values for most Dsum values [all but region of interest (ROI)-max D median (p = 0.08)] were observed to be significantly associated with higher odds of being TRG 0 or 1. Tumor volume of interest (VOI) and ROI volume, ROI kurtosis mean and median, and VOI kurtosis mean and median were not significantly associated with TRG.
Conclusion
Diffusivity derived from the baseline staging MRI, but not diffusion kurtosis or volumetric data, is associated with TRG and therefore shows promise as a potential imaging biomarker to predict the response to neoadjuvant chemotherapy in LARC.
Clinical relevance statement
Diffusivity shows promise as a potential imaging biomarker to predict AJCC TRG following neoadjuvant CRT, which has implications for risk stratification. Patients with TRG 0/1 have 5-year disease-free survival (DFS) of 90–98%, as opposed to those who are TRG 2/3 with 5-year DFS of 68–73%.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benson AB, III, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA (2018) Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 16 (7):874–901. https://doi.org/10.6004/jnccn.2018.0061
Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ (2019) MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics 39 (2):367-387. https://doi.org/10.1148/rg.2019180114
Trakarnsanga A, Gonen M, Shia J, Nash GM, Temple LK, Guillem JG, Paty PB, Goodman KA, Wu A, Gollub M, Segal N, Saltz L, Garcia-Aguilar J, Weiser MR (2014) Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. J Natl Cancer Inst 106 (10). https://doi.org/10.1093/jnci/dju248
Jensen JH, Helpern JA (2010) MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed 23 (7):698-710. https://doi.org/10.1002/nbm.1518
Wang X, Tu N, Qin T, Xing F, Wang P, Wu G (2018) Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer. AJR Am J Roentgenol 211 (4):797-804. https://doi.org/10.2214/ajr.17.19249
Di Trani MG, Nezzo M, Caporale AS, De Feo R, Miano R, Mauriello A, Bove P, Manenti G, Capuani S (2018) Performance of Diffusion Kurtosis Imaging Versus Diffusion Tensor Imaging in Discriminating Between Benign Tissue, Low and High Gleason Grade Prostate Cancer. Acad Radiol. https://doi.org/10.1016/j.acra.2018.11.015
Falk Delgado A, Nilsson M, van Westen D, Falk Delgado A (2018) Glioma Grade Discrimination with MR Diffusion Kurtosis Imaging: A Meta-Analysis of Diagnostic Accuracy. Radiology 287 (1):119–127. https://doi.org/10.1148/radiol.2017171315
Huang Y, Lin Y, Hu W, Ma C, Lin W, Wang Z, Liang J, Ye W, Zhao J, Wu R (2019) Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors. J Magn Reson Imaging 49 (3):845–856. https://doi.org/10.1002/jmri.26249
Hempel JM, Brendle C, Bender B, Bier G, Kraus MS, Skardelly M, Richter H, Eckert F, Schittenhelm J, Ernemann U, Klose U (2019) Diffusion kurtosis imaging histogram parameter metrics predicting survival in integrated molecular subtypes of diffuse glioma: An observational cohort study. Eur J Radiol 112:144–152. https://doi.org/10.1016/j.ejrad.2019.01.014
Wen Z, Chen Y, Yang X, Lu B, Liu Y, Shen B, Yu S (2019) Application of magnetic resonance diffusion kurtosis imaging for distinguishing histopathologic subtypes and grades of rectal carcinoma. Cancer Imaging 19 (1):8. https://doi.org/10.1186/s40644-019-0192-x
Cui Y, Yang X, Du X, Zhuo Z, Xin L, Cheng X (2018) Whole-tumour diffusion kurtosis MR imaging histogram analysis of rectal adenocarcinoma: Correlation with clinical pathologic prognostic factors. Eur Radiol 28 (4):1485–1494. https://doi.org/10.1007/s00330-017-5094-3
Zhu L, Pan Z, Ma Q, Yang W, Shi H, Fu C, Yan X, Du L, Yan F, Zhang H (2017) Diffusion Kurtosis Imaging Study of Rectal Adenocarcinoma Associated with Histopathologic Prognostic Factors: Preliminary Findings. Radiology 284 (1):66–76. https://doi.org/10.1148/radiol.2016160094
Cui Y, Cui X, Yang X, Zhuo Z, Du X, Xin L, Yang Z, Cheng X (2019) Diffusion kurtosis imaging-derived histogram metrics for prediction of KRAS mutation in rectal adenocarcinoma: Preliminary findings. J Magn Reson Imaging. https://doi.org/10.1002/jmri.26653
Feng Q, Yu H, Sun S, Ma Z (2019) The value of diffusion kurtosis imaging in assessing mismatch repair gene expression of rectal carcinoma: Preliminary findings. PLoS One 14 (2):e0211461. https://doi.org/10.1371/journal.pone.0211461
Fusco R, Sansone M, Granata V, Grimm R, Pace U, Delrio P, Tatangelo F, Botti G, Avallone A, Pecori B, Petrillo A (2018) Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters. Abdom Radiol (NY). https://doi.org/10.1007/s00261-018-1801-z
Yu J, Xu Q, Song JC, Li Y, Dai X, Huang DY, Zhang L, Li Y, Shi HB (2017) The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 27 (5):1848–1857. https://doi.org/10.1007/s00330-016-4529-6
Hu F, Tang W, Sun Y, Wan D, Cai S, Zhang Z, Grimm R, Yan X, Fu C, Tong T, Peng W (2017) The value of diffusion kurtosis imaging in assessing pathological complete response to neoadjuvant chemoradiation therapy in rectal cancer: a comparison with conventional diffusion-weighted imaging. Oncotarget 8 (43):75597–75606. https://doi.org/10.18632/oncotarget.17491
Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, https://imagej.nih.gov/ij/, 1997–2018.
Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K (2005) Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine 53 (6):1432–1440. https://doi.org/10.1002/mrm.20508
Elmi A, Hedgire SS, Covarrubias D, Abtahi SM, Hahn PF, Harisinghani M (2013) Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer. Clin Radiol 68 (10):e524–e531. https://doi.org/10.1016/j.crad.2013.05.094
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no relevant conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the Ethical Standards of the Institutional Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Rights and permissions
About this article
Cite this article
Bates, D.D.B., Mazaheri, Y., Lobaugh, S. et al. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer. Abdom Radiol 44, 3701–3708 (2019). https://doi.org/10.1007/s00261-019-02073-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-019-02073-5